Bayer Signs US$1.7 B Deal with Bicycle Therapeutics for Cancer Radiopharmaceuticals

By Amit Kaushik

Pharma Deals Review: Vol 2023 Issue 5 (Table of Contents)

Published: 19 May-2023

DOI: 10.3833/pdr.v2023.i5.2785     ISSN: 1756-7874

Section: Research & Development



In a bid to bolster its radiopharmaceutical portfolio, Bayer has agreed to pay US$45 M upfront to collaborate with Bicycle Therapeutics...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details